trihexyphenidyl has been researched along with Conduct Disorder in 2 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Conduct Disorder: A repetitive and persistent pattern of behavior in which the basic rights of others or major age-appropriate societal norms or rules are violated. These behaviors include aggressive conduct that causes or threatens physical harm to other people or animals, nonaggressive conduct that causes property loss or damage, deceitfulness or theft, and serious violations of rules. The onset is before age 18. (From DSM-IV, 1994)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MANDEL, W | 1 |
| OLIVER, WA | 1 |
| WRIGHT, WB | 1 |
2 other studies available for trihexyphenidyl and Conduct Disorder
| Article | Year |
|---|---|
Withdrawal of maintenance antiparkinson drug in the phenothiazine-induced extrapyramidal reaction.
Topics: Antiparkinson Agents; Conduct Disorder; Humans; Parkinson Disease; Phenothiazines; Trihexyphenidyl | 1961 |
Behaviour disorders associated with Artane treatment of post-encephalitic Parkinsonism.
Topics: Conduct Disorder; Humans; Mental Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; | 1952 |